Jemperli (Dostarlimab-gxly)
- Medicine Name: Jemperli
- Generic Name: Dostarlimab-gxly
- Dosage Form & Strength: Injection: 500 mg/10 mL (50 mg/mL) Solution in a Single-dose Vial
- Manufactured By: GlaxoSmithKline
Medical Uses
Jemperli is a PD-1–blocking antibody used for the treatment of adult patients with mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer that has progressed on or following previous treatment with a platinum-containing regimen and solid tumours, as determined by an FDA-approved test, that have progressed on or following prior treatment and who have no satisfactory alternative treatment options.
Recommended Dosage: The proposed dosage of Jemperli is:
- Dose 1’st through Dose 4’th: 500 mg every 3 weeks.
- Subsequent dosing beginning 3’rd weeks after Dose 4’th (Dose 5’th onwards): 1,000 mg every 6 weeks.
Healthcare professionals recommend the dosage of Jemperli to be administered as an intravenous (IV) infusion over 30 minutes. Treat patients until the disease is progressive or unacceptable toxicity occurs
Warning & Precautions
- Certain immune-mediated adverse reactions, which may be severe or fatal, can emerge in any organ system or tissue. Immune-mediated adverse reactions can emerge anytime after starting a PD-1/PD-L1–blocking antibody.
- One should monitor precisely for signs/symptoms that may be clinical manifestations of underlying immune-mediated adverse reactions. Assess liver enzymes, creatinine, and thyroid function tests at baseline and periodically during Jemperli 500 mg treatment.
- Certain life-threatening infusion-related reactions have been noted with PD-1/PD-L1–blocking antibodies. Evaluate patients for signs/symptoms of infusion-related reactions. Interrupt or slow the infusion rate or permanently discontinue this therapy depending on the severity of the reaction.
- Depending on its mechanism of action, the Jemperli injection can be responsible for causing fetal harm when administered to a pregnant woman. Do not breastfeed during treatment with this medicine and for 4 months after the last dose.
- Fatal and other severe complications can emerge in patients who receive allogeneic HSCT before or after being treated with a PD-1/PD-L1–blocking antibody. Follow patients precisely for findings of transplant-related complications and intervene promptly.
Documentation & Availability
What documents are required to import JEMPERLI to India?
JEMPERLI (dostarlimab-gxly) injection can be imported by patients or government hospitals only in the name of the patients.
The following documentation are needed to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is JEMPERLI available in India?
JEMPERLI (dostarlimab-gxly injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is the facilitator providing input
- On availability of Jemperli injection in India.
- Medicine Price.
- Finding Genuine and reliable sources from Canada, Europe, the USA and Australia
- Ensuring 100% transparency.
JEMPERLI can be made available to patients, doctors and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after receiving a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of JEMPERLI (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for jemperli price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare can source the JEMPERLI from across the globe and can supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Jemperli®?
Jemperli is the trade name of the drug Dostarlimab-gxly.
What are the ingredients of the medicine Jemperil?
The active ingredient in the medicine is Jemperil with inactive ingredient citric acid monohydrate, L-arginine hydrochloride, polysorbate 80, sodium chloride, trisodium citrate dihydrate, and Water for Injection.
Does the FDA approve Jemperli®?
Yes, Jemperli® is approved by the FDA. Date of approval: April 22, 2021.
What is Jemperli®?
Jemperli is a type of immunotherapy named an immune checkpoint inhibitor approved by the FDA for treating dMMR recurrent or advanced endometrial cancer (cancer of the womb) and solid tumours.
What is the dosage and form of Jemperli® supplied?
Jemperli® is supplied as an Injection: 500 mg/10 mL (50 mg/mL) solution in a single-dose vial for intravenous administration.
What are the most common side effects due to Jemperli®?
The most common side effects of Jemperli® include nausea, fatigue/asthenia, diarrhea, constipation, and anemia.
How much does Jemperli® cost in India?
The Jemperli cost in India is sensibly reasonable. To authenticate this endometrial cancer drug, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Jemperli®?
To protect from light, one should store the vials refrigerated at 2-8°C (36-46°F) in the original carton. Neither freeze nor shake the vials.
Is it safe to buy Jemperli® online?
To buy Jemperli (Dostarlimab) online, always look for an authentic, legitimate, WHO-GDP and ISO certified Pharmaceutical Wholesaler/Distributor/Supplier.
What are the Highlights of prescribing information for Jemperli®?
Click Here for full Jemperli prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
